ARTL stock news

ARTL stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

9 wire items

2026-10-26 11:55:00 UTC#514402newconfirmedpress release

Artelo Biosciences to present data on first-in-human FABP5 inhibitor ART26.12 at IASP 2026 World Congress on Pain

globenewswireimportance 0.30trust 0.90Artelo Biosciences, Inc. +0.20ART26.12 +0.30International Association for the Study of Pain 0+2 entities

2026-10-09 21:23:00 UTC#440793newconfirmednews

Artelo Biosciences flagged for non-compliance with Nasdaq $5M market value rule

tradingviewimportance 0.50trust 0.80Artelo Biosciences, Inc. -0.40Nasdaq, Inc. -0.20U.S. Securities and Exchange Commission 0

2026-09-11 12:40:04 UTC#298594newconfirmednews

Artelo Biosciences (ARTL) reports positive Phase II weight gain data in cancer anorexia; glaucoma results pending

quartrimportance 0.40trust 0.50Artelo Biosciences, Inc. +0.60

2026-08-27 12:55:11 UTC#229183newconfirmednews

Artelo Biosciences announces 1-for-9 reverse stock split

seeking alphaimportance 0.40trust 0.80Artelo Biosciences, Inc. -0.30

2026-08-17 12:55:17 UTC#184697newconfirmednews

Artelo Biosciences receives USPTO notice of allowance for ART27.13 formulation patent, extending protection to 2041

reutersimportance 0.40trust 0.80Artelo Biosciences, Inc. +0.40United States Patent and Trademark Office +0.30ART27.13 +0.40

2026-08-13 12:16:01 UTC#171544newconfirmeddata release

Artelo Biosciences reports Q2 2026 GAAP EPS of -$0.89

seeking alphaimportance 0.40trust 0.80Artelo Biosciences, Inc. -0.20

2026-08-13 12:13:35 UTC#171481newconfirmednews

Artelo Biosciences reports Q2 net loss of $2.4M, narrows loss on lower R&D spending

reutersimportance 0.30trust 0.80Artelo Biosciences, Inc. +0.20ART26.12 +0.10ART12.11 +0.10+1 entities

2026-08-11 11:00:33 UTC#158175newforecastnews

Artelo Biosciences (ARTL) Q2 2026 Earnings Preview: Expected EPS Loss of $0.72, Zero Revenue

tradingviewimportance 0.30trust 0.70Artelo Biosciences, Inc. -0.20

2026-07-17 15:34:59 UTC#46840newconfirmednews

ARTL shareholders approve all proposals, including director elections and share increases

quartrimportance 0.30trust 0.70ARTL +0.20